Traphagen Investment Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Traphagen Investment Advisors LLC

$868 Million
Q3 2024

A detailed history of Traphagen Investment Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 455 shares of REGN stock, worth $336,704. This represents 0.06% of its overall portfolio holdings.

Number of Shares

455

Previous 455 -0.0%

Holding current value

$336,704

Previous $478,000 -0.0%

% of portfolio

0.06%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$883.2 - $1071.19 $256,128 - $310,645	-290 Reduced 38.93%	455 $478,000
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $672,504 - $740,045	745 New	745 $718 Million
Q4 2023 Jun 17, 2024	BUY	$775.18 - $881.7 $156,586 - $178,103	202 Added 27.11%	947 $832 Million
Q3 2023 Jun 17, 2024	BUY	$692.45 - $844.37 $279,749 - $341,125	404 Added 54.23%	1,149 $946 Million
Q2 2023 Jun 17, 2024	BUY	$700.03 - $830.35 $282,812 - $335,461	404 Added 54.23%	1,149 $826 Million
Q1 2023 Jun 17, 2024	BUY	$680.49 - $826.97 $2,721 - $3,307	4 Added 0.35%	1,151 $946 Million
Q4 2022 Jun 17, 2024	BUY	$705.89 - $766.39 $283,767 - $308,088	402 Added 53.96%	1,147 $828 Million
Q3 2022 Jun 17, 2024	SELL	$573.97 - $724.32 $4,591 - $5,794	-8 Reduced 0.69%	1,147 $790 Million
Q2 2022 Jun 17, 2024	BUY	$548.35 - $738.84 $224,823 - $302,924	410 Added 55.03%	1,155 $683 Million
Q4 2021 Jun 17, 2024	BUY	$543.48 - $670.97 $219,565 - $271,071	404 Added 54.23%	1,149 $726 Million
Q1 2021 Jun 17, 2024	BUY	$446.73 - $548.2 $180,478 - $221,472	404 Added 54.23%	1,149 $544 Million
Q4 2020 Jun 17, 2024	BUY	$478.3 - $607.98 $2,391 - $3,039	5 Added 0.44%	1,146 $554 Million
Q2 2020 Jun 17, 2024	BUY	$493.32 - $643.92 $195,354 - $254,992	396 Added 53.15%	1,141 $712 Million
Q1 2020 Jun 17, 2024	BUY	$336.18 - $494.43 $133,127 - $195,794	396 Added 53.15%	1,141 $557 Million
Q4 2019 Jun 17, 2024	BUY	$274.13 - $376.51 $231,913 - $318,527	846 Added 113.56%	1,591 $597 Million
Q3 2019 Jun 17, 2024	BUY	$273.46 - $318.39 $231,347 - $269,357	846 Added 113.56%	1,591 $441 Million
Q2 2019 Jun 17, 2024	BUY	$299.6 - $414.82 $253,461 - $350,937	846 Added 113.56%	1,591 $498 Million
Q1 2019 Jun 17, 2024	BUY	$372.08 - $439.57 $314,779 - $371,876	846 Added 113.56%	1,591 $653 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Account

Traphagen Investment Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History